• DOI:10.1111/j.1365-2893.2007.00902.x
Corpus ID: 37659362

Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis

@article{Katz2008LamivudinePR,
  title={Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis},
  author={L. Katz and A. Fraser and A. Gafter‐Gvili and L. Leibovici and R. Tur-Kaspa},
  journal={Journal of Viral Hepatitis},
  year={2008},
  volume={15}
}

L. Katz, A. Fraser, +2 authors R. Tur-Kaspa

Published 2008

Medicine

Journal of Viral Hepatitis

Summary.  To assess the effects of prophylactic lamivudine on reactivation and mortality following immunosuppressive therapy in hepatitis B surface antigen (HBsAg)‐positive patients, we performed a meta‐analysis. Systematic review and meta‐analysis of randomized and nonrandomized prospective controlled trials and retrospective comparative case series were identified through The Cochrane Hepato‐Biliary Group Controlled Trials Register, The Cochrane Central Register of Controlled Trials, MEDLINE… CONTINUE READING

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed